BIO applauds advancement of Precision Medicine Initiative.
Share:
Press Release Summary:
BIO Executive Vice President for Health Policy Dan Durham released statement regarding White House announcement of actions to accelerate the Precision Medicine Initiative. "The data and discoveries resulting from this Initiative may play a critical role in enabling biopharmaceutical companies to develop treatments for patients before or early on in their disease progression, and with therapeutics that are far more effective and focused on the specific characteristics of their particular disease."
Original Press Release:
BIO Applauds Advancement of Precision Medicine Initiative
Washington, D.C. – The Biotechnology Innovation Organization (BIO) Executive Vice President for Health Policy Dan Durham released the following statement regarding yesterday’s White House announcement of actions to accelerate the Precision Medicine Initiative:
“Precision medicine holds great promise for many health care interventions to occur much earlier and with increased accuracy. We applaud this move to begin building a national, large-scale research participant group to accelerate precision medicine technologies. The data and discoveries resulting from this Initiative may play a critical role in enabling biopharmaceutical companies to develop treatments for patients before or early on in their disease progression, and with therapeutics that are far more effective and focused on the specific characteristics of their particular disease.
“We hope that as plans for the Initiative continue to take shape, Congress and the Administration will consider the tremendous potential of this research participant group to implement a multi-phase, multi-study, multi-year program to identify precursors and early signs of chronic diseases such as Alzheimer’s that threaten the health of our loved ones and undermine our nations’ own fiscal health. BIO proposed such a program as part of the 21st Century Cures Initiative.
“We look forward to working with the Administration and Congress to ensure that the discoveries and information resulting from the Initiative will serve to advance patient health and improve the drug development and review processes.”
Upcoming BIO Events
BIO International Convention
June 6-9, 2016
San Francisco, Calif.
13th Annual BIO Asia International Conference
March 15-16, 2016
Tokyo, Japan
World Congress on Industrial Biotechnology
San Diego, CA
April 17-20, 2016
BIO-Europe Spring
April 4-6, 2016
Stockholm, Sweden
About BIO
BIO is the world's largest trade association representing biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products. BIO also produces the BIO International Convention, the world’s largest gathering of the biotechnology industry, along with industry-leading investor and partnering meetings held around the world. BIOtechNOW is BIO's blog chronicling “innovations transforming our world” and the BIO Newsletter is the organization’s bi-weekly email newsletter. Subscribe to the BIO Newsletter.
Contact:
Daniel Seaton
Email: dseaton@bio.org
